Inhibrx Biosciences Ownership | Who Owns Inhibrx Biosciences?


OverviewForecastFinancialsChart

Inhibrx Biosciences Ownership Summary


Inhibrx Biosciences is owned by 30.93% institutional investors, 27.17% insiders, and 41.90% retail investors. Viking global investors lp is the largest institutional shareholder, holding 11.56% of INBX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.32% of its assets in Inhibrx Biosciences shares.

INBX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockInhibrx Biosciences30.93%27.17%41.90%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Viking global investors lp1.79M11.56%$60.21M
Perceptive advisors1.33M8.58%$44.72M
Morgan stanley1.17M7.54%$92.25M
Sanofi1.16M7.48%$91.48M
Hightower advisors870.51K5.62%$68.77M
Blackrock funding, inc. /de777.38K5.02%$61.41M
Vanguard group623.08K4.03%$49.22M
Sofinnova investments440.09K2.85%$14.82M
Capital research global investors421.57K2.72%$33.30M
Woodline partners lp336.59K2.18%$11.34M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sanofi1.16M29.47%$91.48M
Perceptive advisors1.33M1.29%$44.72M
Caligan partners lp236.38K1.04%$7.96M
Sofinnova investments440.09K0.81%$14.82M
Birchview capital, lp31.70K0.81%$1.07M
Pfm health sciences, lp239.64K0.62%$8.07M
Acuta capital partners16.38K0.57%$551.58K
Readystate asset management lp170.16K0.24%$5.73M
Viking global investors lp1.79M0.16%$60.21M
Kennedy capital management161.91K0.12%$5.45M

Top Buyers

HolderShares% AssetsChange
Morgan stanley1.17M0.01%724.87K
Capital research global investors421.57K0.01%421.57K
Perceptive advisors1.33M1.29%349.81K
Caligan partners lp236.38K1.04%236.38K
Readystate asset management lp170.16K0.24%143.32K

Top Sellers

HolderShares% AssetsChange
Blackrock---2.75M
Ra capital management---2.63M
Tcg crossover management---1.75M
Citadel advisors---1.20M
Alpine associates management---1.05M

New Positions

HolderShares% AssetsChangeValue
Capital research global investors421.57K0.01%421.57K$33.30M
Caligan partners lp236.38K1.04%236.38K$7.96M
Norges bank133.30K0.00%133.30K$10.53M
Summittx capital54.14K0.08%54.14K$1.82M
Wellington management group llp29.76K0.00%29.76K$1.00M

Sold Out

HolderChange
Financial gravity asset management-2.00
Jones financial companies lllp-4.00
Ifp advisors-4.00
Lindbrook capital-17.00
Corecap advisors-18.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202567-36.19%4,787,060-54.40%300.67%38-19.15%14-61.11%
Sep 30, 202540-54.02%3,943,558-62.21%250.56%11-64.52%14-58.82%
Jun 30, 202586-10.42%10,434,307-3.62%671.38%303.45%34-5.56%
Mar 31, 20259-91.59%2,655,100-76.21%180.35%2-95.74%2-93.55%
Dec 31, 20241072.88%11,162,06025.45%722.18%47-20.34%3172.22%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.22M2.32%94.03K
Vanguard Institutional Extnd Mkt Idx Tr394.10K0.75%-76.00
The Merger Fund A198.51K0.38%198.51K
Vanguard Russell 2000 ETF129.24K0.25%1.43K
Meridian Small Cap Growth Legacy123.63K0.24%-39.95K
ArrowMark Small Cap Gro123.63K0.24%-39.95K
NT R2000 Index Fund - NL95.63K0.18%-1.93K
NT R2000 Index Fund - DC - NL - 275.94K0.14%-886.00
NT R2000 Growth Index Fund - NL65.89K0.13%-2.36K
iShares Russell 2000 Small-Cap Idx Instl64.02K0.12%-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 07, 2025VIKING GLOBAL INVESTORS LP-Sell$9.95M
Oct 07, 2025VIKING GLOBAL INVESTORS LP-Sell$526.16K
Oct 07, 2025VIKING GLOBAL INVESTORS LP-Sell$807.60K
Nov 20, 2024Kayyem Jon Faiz-Buy$266.10K
Nov 19, 2024Kayyem Jon Faiz-Buy$495.71K

Insider Transactions Trends


DateBuySell
2025 Q4-3
2025 Q2--
2025 Q1--
2024 Q43-
2024 Q37-

INBX Ownership FAQ


Who Owns Inhibrx Biosciences?

Inhibrx Biosciences shareholders are primarily institutional investors at 30.93%, followed by 27.17% insiders and 41.90% retail investors. The average institutional ownership in Inhibrx Biosciences's industry, Biotech Stocks , is 381.47%, which Inhibrx Biosciences falls below.

Who owns the most shares of Inhibrx Biosciences?

Inhibrx Biosciences’s largest shareholders are Viking global investors lp (1.79M shares, 11.56%), Perceptive advisors (1.33M shares, 8.58%), and Morgan stanley (1.17M shares, 7.54%). Together, they hold 27.69% of Inhibrx Biosciences’s total shares outstanding.

Does Blackrock own Inhibrx Biosciences?

BlackRock is not among the top 10 institutional shareholders of Inhibrx Biosciences.

Who is Inhibrx Biosciences’s biggest shareholder by percentage of total assets invested?

Sanofi is Inhibrx Biosciences’s biggest shareholder by percentage of total assets invested, with 29.47% of its assets in 1.16M Inhibrx Biosciences shares, valued at 91.48M$.

Who is the top mutual fund holder of Inhibrx Biosciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Inhibrx Biosciences shares, with 2.32% of its total shares outstanding invested in 1.22M Inhibrx Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools